Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | retinoic acid receptor, beta | Starlite/ChEMBL | References |
Homo sapiens | retinoic acid receptor, gamma | Starlite/ChEMBL | References |
Homo sapiens | retinoic acid receptor, alpha | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_131607 | All targets in OG5_131607 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | Get druggable targets OG5_131607 | All targets in OG5_131607 |
Loa Loa (eye worm) | nuclear receptor nhr-7B | Get druggable targets OG5_131607 | All targets in OG5_131607 |
Brugia malayi | nuclear hormone receptor | Get druggable targets OG5_131607 | All targets in OG5_131607 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0769 | 0.9524 | 0.977 |
Echinococcus multilocularis | leucine aminopeptidase protein | 0.0116 | 0.1032 | 0.5305 |
Toxoplasma gondii | leucyl aminopeptidase LAP | 0.0116 | 0.1032 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | leucyl aminopeptidase | 0.0116 | 0.1032 | 0.5 |
Loa Loa (eye worm) | nuclear receptor nhr-7B | 0.0787 | 0.9749 | 1 |
Trypanosoma cruzi | metallo-peptidase, Clan MF, Family M17, putative | 0.0116 | 0.1032 | 0.5 |
Trypanosoma brucei | metallo-peptidase, Clan MF, Family M17 | 0.0116 | 0.1032 | 0.5 |
Trypanosoma cruzi | cytosolic leucyl aminopeptidase, putative | 0.0116 | 0.1032 | 0.5 |
Mycobacterium ulcerans | leucyl aminopeptidase | 0.0116 | 0.1032 | 0.5 |
Echinococcus multilocularis | geminin | 0.0186 | 0.1945 | 1 |
Chlamydia trachomatis | cytosol aminopeptidase | 0.0116 | 0.1032 | 0.5 |
Echinococcus granulosus | geminin | 0.0186 | 0.1945 | 1 |
Leishmania major | cytosolic leucyl aminopeptidase,metallo-peptidase, Clan MF, Family M17 | 0.0116 | 0.1032 | 0.5 |
Brugia malayi | nuclear hormone receptor | 0.0787 | 0.9749 | 1 |
Echinococcus granulosus | leucine aminopeptidase protein | 0.0116 | 0.1032 | 0.5305 |
Plasmodium vivax | M17 leucyl aminopeptidase, putative | 0.0116 | 0.1032 | 0.5 |
Mycobacterium tuberculosis | Probable aminopeptidase PepB | 0.0116 | 0.1032 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.1945 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.1945 | 1 |
Mycobacterium leprae | Probable cytosol aminopeptidase PepB | 0.0116 | 0.1032 | 0.5 |
Plasmodium falciparum | M17 leucyl aminopeptidase | 0.0116 | 0.1032 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 0.5 uM | Antiproliferative activity against HMVE cells | ChEMBL. | 17489579 |
Inhibition (functional) | = 30 % | Inhibition of HMVE cell proliferation at 0.5 uM relative to control | ChEMBL. | 17489579 |
Kd (binding) | = 3.3 nM | Apparent binding constant against Retinoic acid receptor gamma in HeLa cell GAl-4 transactivation assay | ChEMBL. | 8691435 |
Kd (binding) | = 3.3 nM | Apparent binding constant against Retinoic acid receptor gamma in HeLa cell GAl-4 transactivation assay | ChEMBL. | 8691435 |
Kd (binding) | = 50 nM | Apparent binding constant for Retinoic acid receptor beta in HeLa cellGAL-4 transactivation assay | ChEMBL. | 8691435 |
Kd (binding) | = 50 nM | Apparent binding constant for Retinoic acid receptor beta in HeLa cellGAL-4 transactivation assay | ChEMBL. | 8691435 |
Kd (binding) | = 700 nM | Apparent binding constant against Retinoic acid receptor alpha in HeLa cell GAl-4 transactivation assay | ChEMBL. | 8691435 |
Kd (binding) | = 700 nM | Apparent binding constant against Retinoic acid receptor alpha in HeLa cell GAl-4 transactivation assay | ChEMBL. | 8691435 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.